NCT00433550 Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer Status COMPLETED Phase PHASE2
NCT00430027 Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma Status TERMINATED Phase NA
NCT00427713 Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE3
NCT00425841 Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00425425 Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT00422864 A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer Status COMPLETED Phase PHASE2
NCT00418093 Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma Status TERMINATED Phase PHASE2
NCT00416494 Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00415298 AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer Status UNKNOWN Phase NA
NCT00411229 Capecitabine and Oxaliplatin Adjuvant Study in Stomach Cancer Status COMPLETED Phase PHASE3
NCT00408772 Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT00408564 Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00408551 Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver Status UNKNOWN Phase PHASE2
NCT00406302 Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00403988 Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma Status TERMINATED Phase PHASE2
NCT00403624 Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00399750 TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00398320 Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors Status COMPLETED Phase PHASE2
NCT00383695 Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer Status UNKNOWN Phase PHASE2
NCT00381862 Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOX Status COMPLETED Phase PHASE2